Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Can smartphone nudges reduce evening snacking in type 2 diabetes? Explore new CGM research, early results, and implications for personalized care.
Read More »When Evening Snacking Strikes, Can a Smartphone Nudge Change What Happens Next?
High-Fiber Diet vs. Metformin: A Small Trial Delivers a Surprising Result
A small 84-day trial found greater A1C and BMI improvements with a high-fiber diet than metformin. Explore the results, limitations, and clinical implications.
Read More »After DKA or Repeated Low Blood Sugar, Could Attention Problems Linger?
Explore how hypoglycemia and DKA may be linked to attention difficulties in children with type 1 diabetes and what new research reveals.
Read More »Feeding at Night, Dosing by Day: Why Parenteral Nutrition Makes Insulin Management So Difficult
Discover why parenteral nutrition complicates insulin dosing and how CGM-guided adjustments improved glucose control in a small clinical study.
Read More »High Altitude, Low Oxygen, Same CGM? Researchers Put Sensor Accuracy to the Test
New research examines CGM accuracy in hypoxia, including Dexcom G6 and FreeStyle Libre performance during reduced oxygen exposure.
Read More »Gestational Diabetes Without Going Low-Carb? A Trial Tests a Different Nutrition Strategy
A randomized trial compares complex carbohydrates with a lower-carb diet in gestational diabetes and explores what the findings mean for nutrition counseling.
Read More »Three Weeks of Treatment, Months of Better Glucose? A New Diabetes Drug Is Testing an Unusual Idea
Early Phase 1b data suggest balomenib may improve glucose control after treatment ends. Learn what the results could mean for type 2 diabetes.
Read More »The First Years After a Type 2 Diabetes Diagnosis May Matter More Than We Thought
Early hyperglycemia may influence cancer risk after type 2 diabetes diagnosis. See what a large cohort study found about early glycemic exposure.
Read More »378 Trials, 113,000+ Participants: What Actually Works to Stop Prediabetes From Becoming Diabetes?
Discover what 378 trials involving 113,000+ participants reveal about prediabetes treatment, lifestyle changes, metformin, and incretin therapies.
Read More »Prediabetes Isn’t One-Size-Fits-All: Why the Same Exercise Plan Gets Different Results
New research shows the prediabetes exercise response may differ by glucose phenotype, highlighting the potential for more personalized prevention plans.
Read More »